Therapeutic Potential of Graphene Quantum Dots on Pterygium Cells
Year: 2025
Type: article
Abstract: Purpose: To evaluate the therapeutic potential of graphene quantum dots (GQDs) in modulating key pathological processes in pterygium, including abnormal cell proliferation, migration, and extracellular matrix remodeling. Methods: Primary fibroblast cells from human pterygium and conjunctival tissues were cultured and treated with GQDs (6.25-100 µg/mL). Cell cytotoxicity and viability were assessed using live/dead and CCK-8 assays. Cell migration was evaluated via scratch wound-healing assays. Microtubule integrity was analyzed using α-tubulin immunocytochemistry and super-resolution stochastic optical reconstruction microscopy imaging. Expression of pathological proteins (cyclin D1, CDK2, periostin, matrix metalloproteinase [MMP]-3, and MMP-9) was quantified by Western blotting. Results: GQDs selectively impaired pathological behaviors in pterygium fibroblasts, reducing viability and migration in a dose-dependent manner, with minimal effects on conjunctival fibroblasts. Stochastic optical reconstruction microscopy imaging revealed GQD-induced microtubule fragmentation in pterygium fibroblasts. GQDs also significantly downregulated cyclin D1, CDK2, periostin, MMP-3, and MMP-9. Conclusions: GQDs suppress multiple pathologic features of pterygium, including selective cytotoxicity, downregulation of key molecular mediators (cyclin D1, periostin, MMP-3, and MMP-9), and a novel mechanism involving microtubule fragmentation. These findings support the potential of GQDs as a noninvasive therapeutic strategy to suppress pterygium progression and decrease postoperative recurrence.
DOI: 10.1167/iovs.66.14.9
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,850
OpenAlex ID: W4415869212